Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous dexmedetomidine for bleeding control and hemodynamic stability during septorhinoplasty
IRCT20210415050976N12Phase 2Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial comparing Dexmedetomidine plus routine anesthesia with Placebo plus routine anesthesia (2 arms). Primary endpoints: Hemodynamic symptoms, Surgeon satisfaction and 1 more. Started Jan 2023; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on IRCT20210415050976N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210415050976N12.